ARCHIVES

Senate Subcommittee Votes $970 Million for NCI In FY 1980; Magnuson Cancer Support Holds Firm

This article is from The Cancer Letter archive.

Vol. 04 No. 25 | June 23, 1978

Download PDF Visit The Full Archive

Related Articles

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012

Varmus: Why are scientific societies obstructing public access to research results?

May 20, 2005

FDA Urges Moratorium On Sale, Use of Silicone Breast Implants

January 10, 1992

Challoner: We Recommended FDA Replace 510(k) Clearance

July 4, 2014

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

February 24, 2006

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006